|
5
|
Detsky AS, Tugwell PX How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ
– A Laupacis, D Feeny
- 1992
|
|
2
|
Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation. Health Econ 12(10):837–848
– J Karnon
- 2003
|
|
2
|
Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 5
– O’Brien BJ, Drummond MF
- 1994
|
|
3
|
Elixhauser A. Estimating costs in the economic evaluation of medical technologies
– Luce BR
- 1990
|
|
2
|
The value of implementation and the value of information: Combined and uneven development
– E Fenwick, Sculpher M Claxton, K and
|
|
1
|
et al. EURONHEED: overview of the current economic evaluation databases and their usefulness. College des Economistes de la Sante: La Lettre du College
– R Aguiar-Ibanez, J Nixon, J Glanville, D Craig, S Rice, J Christie
|
|
1
|
et al. Economic evaluation databases as an aid to healthcare decision makers and researchers. Expert Rev Pharmacoeconomics Outcomes Res
– R Aguiar-Ibanez, J Nixon, J Glanville, D Craig, S Rice, J Christie
|
|
1
|
Health economic evaluations: how to find them
– V Alton, I Eckerlund, A Norlund
|
|
1
|
How do we judge the quality of economic evaluations? Journal of Clinical Excellence
– N Armstrong, M Drummond, J Nixon, D Craig, J Glanville
|
|
1
|
Are the best available clinical effectiveness data used in economic evaluations of drug therapies
– D Craig, B Hanratty, M Drummond, J Nixon, S Rice, J Christie
- 2005
|
|
1
|
Guidelines for economic evaluation: from critical appraisal to study design
– L Davies, K Payne, D Craig, J Nixon, N Armstrong
|
|
1
|
Making economic evaluations more accessible to health care decision-makers. Eur J Health Econ
– M Drummond
|
|
1
|
How do we judge the quality of economic evaluations
– M Drummond, A Armstrong
- 2002
|
|
1
|
de Pouvourville G. Can economic evaluations be made transferable
– M Drummond, S Boulenger, J Nixon, P Ulmann, S Rice
|
|
1
|
Are the best available, most applicable clinical effectiveness data used in economic evaluations of drug therapies? ISPOR 7th Annual European Conference; 2004 Oct 24-26
– M Drummond, B Hanratty, J Nixon, J Christie
- 2005
|
|
1
|
Principles of economic appraisal in health care
– Drummond MF
- 1980
|
|
1
|
Glanville JM, de Pourvourville G. The European Network of Health Economic Evaluation Databases (EURONHEED) project. Hull York Medical School (HYMS) Research Conference; 2004 Feb 11
– Drummond MF, S Boulenger, J Nixon, P Ulmann
- 2003
|
|
1
|
Making sense of meta-analysis. Pharmacoepidemiol Drug Saf
– M Egger, Davey Smith G, F Song
|
|
2
|
Meta-analysis and its problems
– Eysenck HJ
|
